Insider trades
Kate Haviland, Director of Bicara Therapeutics BCAX, has filed 0 purchases and 12 sales on the open market. The latest trade was on 06/09.
Kate Haviland
Director
- Company
- Bicara Therapeutics BCAX
- First filing
- 23/03/03
- Trades
- 38 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- No record
- Last trade
- 06/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/04/01 | 25/04/03 | 2,498 sh4 trades | $86.65avg. | $216,460.72 | −1.5% | |
| Open-market sale | 25/03/05 | 25/03/07 | 16,151 sh | $88.80 | $1,434,208.8 | −8.8% | |
| Open-market sale10b5-1 plan | 25/01/21 | 25/01/23 | 1,446 sh | $110.24 | $159,407.04 | −1.0% | |
| Open-market sale10b5-1 plan | 24/11/29 | 24/12/03 | 2,353 sh3 trades | $96.60avg. | $227,304.36 | −1.5% | |
| Open-market sale | 24/03/07 | 24/03/11 | 12,464 sh | $90.69 | $1,130,360.16 | −7.5% | |
| Open-market sale | 23/03/06 | 23/03/08 | 6,640 sh2 trades | $45.69avg. | $303,353.96 | −5.0% |